NO810723L - Hypoxanfinderivater. - Google Patents

Hypoxanfinderivater.

Info

Publication number
NO810723L
NO810723L NO810723A NO810723A NO810723L NO 810723 L NO810723 L NO 810723L NO 810723 A NO810723 A NO 810723A NO 810723 A NO810723 A NO 810723A NO 810723 L NO810723 L NO 810723L
Authority
NO
Norway
Prior art keywords
acid
sup
compounds
unsubstituted
formulawhere
Prior art date
Application number
NO810723A
Other languages
English (en)
Other versions
NO155579C (no
NO155579B (no
Inventor
Lionel Norton Simon
Alfredo Giner-Sorolla
Alvin Guttag
Original Assignee
Newport Pharmaceuticals
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals, Sloan Kettering Inst Cancer filed Critical Newport Pharmaceuticals
Publication of NO810723L publication Critical patent/NO810723L/no
Publication of NO155579B publication Critical patent/NO155579B/no
Publication of NO155579C publication Critical patent/NO155579C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO810723A 1980-03-14 1981-03-03 Analogifremgangsmaate for fremstilling av terapeutisk aktive hypoxantinderivater. NO155579C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/130,334 US4340726A (en) 1980-03-14 1980-03-14 Esters

Publications (3)

Publication Number Publication Date
NO810723L true NO810723L (no) 1981-09-15
NO155579B NO155579B (no) 1987-01-12
NO155579C NO155579C (no) 1987-04-22

Family

ID=22444200

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810723A NO155579C (no) 1980-03-14 1981-03-03 Analogifremgangsmaate for fremstilling av terapeutisk aktive hypoxantinderivater.

Country Status (26)

Country Link
US (1) US4340726A (no)
EP (1) EP0036077B1 (no)
JP (1) JPS572287A (no)
KR (1) KR850000320B1 (no)
AT (1) ATE8995T1 (no)
AU (1) AU535052B2 (no)
CA (1) CA1159827A (no)
CS (1) CS235514B2 (no)
DD (1) DD156813A5 (no)
DE (1) DE3165476D1 (no)
DK (1) DK154768C (no)
ES (1) ES500321A0 (no)
FI (1) FI67848C (no)
GR (1) GR74807B (no)
HU (1) HU187324B (no)
IE (1) IE51019B1 (no)
IL (1) IL62258A (no)
IN (1) IN155441B (no)
NO (1) NO155579C (no)
NZ (1) NZ196295A (no)
PH (1) PH19148A (no)
PL (1) PL129094B1 (no)
PT (1) PT72665B (no)
RO (1) RO82509A (no)
YU (1) YU41973B (no)
ZA (1) ZA811181B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
JPS58135878A (ja) * 1981-09-22 1983-08-12 Suntory Ltd 新規アイラントン誘導体及びその製造法
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
JP3005959B2 (ja) * 1989-03-31 2000-02-07 ヤンマー農機株式会社 乗用田植機における植付部伝動構造
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ATE499103T1 (de) 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
SG149829A1 (en) * 2003-10-03 2009-02-27 3M Innovative Properties Co Pyrazolopyridines and analogs thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2940966A (en) * 1958-05-15 1960-06-14 Daniel R Bullard Glucoside of 2-amino-4-hydroxy-6-(1', 2'-dihydroxypropyl)-pteridine
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
DE2714883A1 (de) * 1977-04-02 1978-10-12 Basf Ag Nicht-glykosidische theophyllin- zucker-derivate
JPS55113786A (en) * 1979-02-23 1980-09-02 Toyo Jozo Co Ltd Novel substance, nepranosin b or f and its preparation
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity

Also Published As

Publication number Publication date
DK154768B (da) 1988-12-19
YU41973B (en) 1988-04-30
DK115081A (da) 1981-09-15
DE3165476D1 (en) 1984-09-20
EP0036077A3 (en) 1982-01-13
YU65181A (en) 1984-02-29
FI67848C (fi) 1985-06-10
IL62258A (en) 1984-12-31
CS235514B2 (en) 1985-05-15
EP0036077B1 (en) 1984-08-15
IN155441B (no) 1985-02-02
DD156813A5 (de) 1982-09-22
PL230115A1 (no) 1981-11-13
PT72665B (en) 1982-06-08
KR850000320B1 (ko) 1985-03-20
HU187324B (en) 1985-12-28
IE51019B1 (en) 1986-09-03
NZ196295A (en) 1983-09-02
DK154768C (da) 1989-06-19
ES8202825A1 (es) 1982-03-01
JPS572287A (en) 1982-01-07
RO82509B (ro) 1983-08-30
EP0036077A2 (en) 1981-09-23
GR74807B (no) 1984-08-12
PL129094B1 (en) 1984-03-31
US4340726A (en) 1982-07-20
RO82509A (ro) 1983-09-26
ATE8995T1 (de) 1984-09-15
AU6802581A (en) 1981-09-17
ES500321A0 (es) 1982-03-01
PH19148A (en) 1986-01-15
AU535052B2 (en) 1984-03-01
PT72665A (en) 1981-04-01
NO155579C (no) 1987-04-22
JPH031311B2 (no) 1991-01-10
FI810774L (fi) 1981-09-15
IE810552L (en) 1981-09-14
ZA811181B (en) 1982-01-27
CA1159827A (en) 1984-01-03
NO155579B (no) 1987-01-12
KR830005224A (ko) 1983-08-03
FI67848B (fi) 1985-02-28

Similar Documents

Publication Publication Date Title
NO810723L (no) Hypoxanfinderivater.
UA6345A1 (uk) Спосіб одержання похідного авермектіна
ES465291A1 (es) Procedimiento para preparar esteres de acidos ciclopropano- carboxilicos con alcoholes bencilicos halogenados.
NZ211954A (en) Reaction products of alkenylsuccinic acid, esters or anhydrides with aromatic amines and lubricant compositions thereof
ES8606243A1 (es) Un procedimiento para producir un ester
IE821738L (en) Ml-236b derivatives
ATE68466T1 (de) Phenolveresterung, katalysiert durch phosphoriger saeure.
IE34348B1 (en) Esters of rho-biphenylylacetic acid
ES463859A1 (es) Procedimiento para la preparacion de una sustancia de inocu-lacion para impedir sedimentaciones petrificantes en medios acuosos.
EP0220892A3 (en) Cold flow improving fuel additive compound and fuel composition containing same
AU680325B2 (en) Process for the carbonylation of an acetylenically unsaturated compound
JPS5396085A (en) Fatty acid esterified mannanphosphoric acid
JPS5661377A (en) Optically active cephaloasporin analog
ES326105A1 (es) Un metodo de producir acido glutanico.